Association of antineutrophil cytoplasmic antibody (ANCA) specificity with demographic and clinical characteristics of patients with ANCA‑associated vasculitides [0.03%]
抗中性粒细胞胞浆抗体(ANCA)特异性与ANCA相关血管炎患者人口统计学特征及临床表现的相关性分析
Krzysztof Wójcik,Anna Masiak,Radosław Jeleniewicz et al.
Krzysztof Wójcik et al.
Introduction: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is characterized by the presence of proteinase‑3 (PR3) or myeloperoxidase (MPO) ANCA. In over 90% of cases, PR3‑ANCA is associated wit...
Multicenter Study
Polish archives of internal medicine. 2022 Mar 30;132(3):16187. DOI:10.20452/pamw.16187 2022
More cavities and a higher body mass index in diabetic compared with nondiabetic patients with tuberculosis: an observational study [0.03%]
糖尿病合并肺结核患者的龋齿和身体质量指数高于非糖尿病合并肺结核患者：一项观察性研究
Marcin Skowroński,Wojciech Michalski,Dorota Zozulińska-Ziółkiewicz et al.
Marcin Skowroński et al.
Observational Study
Polish archives of internal medicine. 2022 Jan 28;132(1):16186. DOI:10.20452/pamw.16186 2022
Impact of therapeutic thoracentesis and pleural pressure changes on breathing pattern, dyspnea, lung function, and arterial blood gases [0.03%]
胸腔穿刺的治疗作用及其对胸膜压力、呼吸模式、气促、肺功能和动脉血液气体的影响
Monika Zielinska-Krawczyk,Anna M Stecka,Elzbieta M Grabczak et al.
Monika Zielinska-Krawczyk et al.
Introduction: Therapeutic thoracentesis is highly effective in providing symptomatic improvement in patients with large volume pleural effusion (PE). However, some physiological effects of pleural fluid (PF) withdrawal ar...
Observational Study
Polish archives of internal medicine. 2022 Apr 28;132(4):16185. DOI:10.20452/pamw.16185 2022
Prevalence of self‑reported heart failure in the adult Polish population: results of the NATPOL 2011 study [0.03%]
波兰成人中自报心力衰竭患病率：NATPOL 2011研究结果
Aleksandra Puch-Walczak,Piotr Bandosz,Tomasz Grodzicki et al.
Aleksandra Puch-Walczak et al.
Introduction: Chronic heart failure (CHF) is a growing medical and economic problem, especially in Central and Eastern Europe. However, only a few studies analyzed the prevalence of CHF in this region. ...
Will molnupiravir be a game changer in our efforts to safe COVID-19 outpatients? [0.03%]
莫努匹拉韦会改变我们对新冠病毒门诊患者的治疗思路吗？
Jacek Mrukowicz,Bram Rochwerg,Roman Jaeschke
Jacek Mrukowicz
In search for the right way in medical care of older adults: navigating between geriatrician and other specialties on the sea of multimorbidity [0.03%]
在老年医学领域寻求正确的方向：在多病共存的大海上寻找专科和全科之间的平衡点
Małgorzata Stompór,Tomasz Stompór
Małgorzata Stompór
Sodium-glucose cotransporter 2 inhibitors and heart failure decompensation: considerations on body composition and skeletal mass [0.03%]
钠-葡萄糖共转运蛋白2抑制剂与心力衰竭恶化：体成分和骨骼肌的问题思考
Dimitrios Patoulias,Christodoulos Papadopoulos,Michael Doumas
Dimitrios Patoulias
Sodium-glucose cotransporter 2 inhibitors and heart failure decompensation: considerations on body composition and skeletal mass. Authors' reply [0.03%]
钠-葡萄糖共转运蛋白2抑制剂与心力衰竭失代偿：关于体质组成和骨骼质量的考虑——作者回应
Jacek Budzyński,Anna Wawrzeńczyk
Jacek Budzyński
The challenges and pitfalls of treating cardiogenic shock with venoarterial extracorporeal membrane oxygenation [0.03%]
静脉动脉体外膜肺氧合治疗心源性休克的挑战及陷阱
Paweł Piwowarczyk,Michał Borys,Mirosław Czuczwar
Paweł Piwowarczyk
Challenges for Polish Archives of Internal Medicine in 2021: what is new in 2022? [0.03%]
波兰内科档案在2021年的挑战：2022年的新变化？
Anetta Undas,Grzegorz Gajos,Tomasz Stompór
Anetta Undas